All In Biotech

Drug Trial Radar · NCT02179294

A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour

Last checked: Nov 20, 2026Latest source record: Oct 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 401 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

401

Actual

Start

May 2014

Primary completion

Sep 2016

Study completion Sep 2016

Sponsor

Lead sponsor
University of BirminghamAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Heartlands Hospital; Good Hope Hospital; Birmingham Women's NHS Foundation Trust; York Hospital; University Hospital of North Midlands; Frimley Park Hospital; Bradford Royal Infirmary; Stoke Mandeville Hospital; Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK); Medway Maritime Hospital; Northwick Park Hospital; Homerton University Hospital; City Hospital Birmingham; Warwick Hospital; University Hospital Coventry
First posted
Jul 1, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Childbirth can be an extremely painful and the provision of pain relief during labour is a vital component of a positive maternal experience. The majority of women who deliver in modern obstetric units choose a pharmacological method of pain relief, including Entonox, the injection of opioids or epidural placement. The commonest opioid used in labour is pethidine administered by intramuscular (im) injection. The effectiveness of pain relief provided by pethidine has long been challenged. Its shortcomings are more serious when set against known side effects including maternal sedation, nausea and potential transfer across the placenta to the foetus. More than a third of women who receive pethidine subsequently require an epidural due to inadequate pain relief. Epidurals provide highly effective pain relief, but increase the risk of a forceps or suction delivery resulting in prolonged hospital stay. Therefore, there is a clear need for a safe, effective, easy to administer analgesic alternative.

Conditions

  • Pain Relief in Labour

Interventions

  • PethidineDrug

    100mg by intramuscular injection, up to 4 hourly in frequency (up to a maximum of 4 doses). The maximum dose being 400mg in 24 hours.

  • RemifentanilDrug

    Dedicated intravenous cannula for remifentanil administration PCA protocol * PCA bolus remifentanil 40 μg * Lockout interval 2 minutes In the event of excess sedation being recorded by regular observation of respiratory function, the regimen will be altered by reduction of the remifentanil bolus dose to 30 μg with a lock-out interval of 2 minutes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of women who receive epidural analgesia for pain relief in labour, in each group, after randomisation.Time frame: At labour

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Birmingham Clinical Trials Unit

    Birmingham, West Midlands, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.